RedHill Biopharma (RDHL) Earnings
|
Expand Research on RDHL
| Next EPS Date | 6/8/26 | EPS Growth Rate | N/A |
|---|---|---|---|
| Average EPS % Beat Rate | +15.8% | Revenue Growth Rate | N/A |
| Average % Move 1-Wk after EPS | +16.3% | Normal Earnings Time | Before Open |
| Date | Qtr | EPS | Cons. | Surprise | Revs | Cons. | Gd. | 1-Week % | 1-Day % | Details | |
|---|---|---|---|---|---|---|---|---|---|---|---|
6/8/26  |
Q126 | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | ||
| 3/27/26 |
Q425 | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | ||
| 3/26/26 |
Q425 | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | ||
| 3/25/26 |
Q425 | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | ||
| 3/24/26 |
Q425 | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | ||
| 3/23/26 |
Q425 | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | ||
| 3/19/26 |
Q425 | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | ||
| 3/17/26 |
Q425 | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
